"Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review." by Peter A. Everts

Article

Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review.

Regenerative Therapy (2019)

Peter A. Everts, Gulf Coast Biologics, Scientific and Research Department, Fort Myers, FL, USA.
Gerard A. Malanga, Rutgers University
Rowan V. Paul, Dartmouth College
Rowan V. Paul, California Pacific Medical Center
Joshua B. Rothenberg, Boca Raton Regional Hospital
Natalie Stephens, Biosciences Research Associates, Cambridge, MA, USA.
Kenneth R. Mautner, Emory University

Link

Disciplines

Publication Date

May 10, 2019

DOI

10.1016/J.RETH.2019.03.009

Citation Information

Peter A. Everts, Gerard A. Malanga, Rowan V. Paul, Rowan V. Paul, et al.. "Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review." Regenerative Therapy Vol. 11 (2019) p. 56 - 64
Available at: http://works.bepress.com/joshua-rothenberg/5/